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Coactivators CREB-binding protein and p300 play
important roles in mediating the transcriptional
activity of p53. Until now, however, no detailed struc-
tural information has been available on howany of the
domains of p300 interact with p53. Here, we report
the NMR structure of the complex of the Taz2 (C/
H3) domain of p300 and the N-terminal transactiva-
tion domain of p53. In the complex, p53 forms a short
a helix and interactswith the Taz2 domain through an
extended surface. Mutational analyses demonstrate
the importance of hydrophobic residues for complex
stabilization. Additionally, they suggest that the
increased affinity of Taz2 for p531–39 phosphorylated
at Thr18 is due in part to electrostatic interactions of
the phosphate with neighboring arginine residues in
Taz2. Thermodynamic experiments revealed the im-
portance of hydrophobic interactions in the complex
of Taz2 with p53 phosphorylated at Ser15 and Thr18.
INTRODUCTION
The tumor suppressor p53 is a central transcription factor that
integrates many stress signals following DNA damage, resulting
in transcriptional activation of key genes involved in cell cycle
arrest and apoptosis (Das et al., 2008). Its functional activity is
initiated in part by site-specific recruitment of the histone acetyl-
transferase coactivators CREB-binding protein (CBP) and p300,
which promote local chromatin unwinding (Barlev et al., 2001;
Liu et al., 2003). In addition, CBP and p300 acetylate p53 on
six C-terminal lysine residues; these modifications further stabi-
lize and activate the protein (Gu and Roeder, 1997; Ito et al.,
2001; Sakaguchi et al., 1998).
CBPandp300areparalogscomposedofsevendistinctdomains
arranged in a common architecture. Among those domains are
two transcriptional adaptor zinc-binding (Taz) domains, Taz1
(C/H1) and Taz2 (C/H3), which mediate protein-protein interac-
tions important for the transcriptional coactivator functions of
these proteins. Taz1 has been found to interact with HIF-1a and
CITED2, whereas Taz2 binding partners include E1A, GATA-1,
and E2F (Goodman and Smolik, 2000). Furthermore, both202 Structure 17, 202–210, February 13, 2009 ª2009 Elsevier Ltd Adomains have been shown to interact with p53 through its
N-terminal transactivation domain (TAD) (Avantaggiati et al.,
1997; Grossman et al., 1998). The p53 TAD can be divided into
two subdomains, TAD1 (composed of residues 1–40) and TAD2
(composed of residues 41–61), which can independently activate
transcription (Candau et al., 1997). TAD1 has been shown to
interact with both Taz1 and Taz2 of p300 (Polley et al., 2008; Teu-
fel et al., 2007). TAD2 plays a role in binding to Taz1 (Polley et al.,
2008), and we recently determined that TAD2 is also able to
interact with Taz2 with an affinity similar to that observed for
TAD1 (Jenkins et al., 2009).
In response to DNA damage-inducing stress, the p53 TAD can
be phosphorylated at up to ten different sites by multiple kinases
(Appella and Anderson, 2001). These modifications disrupt
MDM2 binding, thereby preventing ubiquitylation and degrada-
tion of p53 (Bottger et al., 1999; Craig et al., 1999). The posttrans-
lational modifications have also been shown to modulate the
interaction of p53 with other proteins. For example, binding of
p53 to MDM2 is weakened by phosphorylation of Thr18 (Sakagu-
chi et al., 2000), whereas its binding to the p62 subunit of TFIIH is
strengthened by phosphorylation of Ser46 and Thr55 (Di Lello
et al., 2006). In addition, we and others have recently demon-
strated that phosphorylation of p53 increases its affinity for
p300, including binding to the Taz1 and Taz2 domains (Polley
et al., 2008) (Jenkins et al., 2009).
The recruitment of p300 to gene promoters by p53 is critical for
the transactivation activity of p53. Chromatin-bound p53 recruits
p300 to thepromoter, resulting in localizedacetylationofhistones,
thereby facilitating transcription (Espinosa and Emerson, 2001).
The amount of p300 binding by p53 correlates with the extent of
histoneacetylation and the inductionof p53-dependent transcrip-
tion (Liu et al., 2003). Inhibitionofbindingbycompetitorproteinsor
downregulation of CBP or p300 by siRNA has been found to
repress p53-mediated transcription and reduce local histone
acetylation at p53 promoters (Hsu et al., 2004; Liu et al., 2003;
Luo et al., 2001; Vaziri et al., 2001). Furthermore, the interaction
betweenp53and theTaz2domainofp300 isespecially important,
because it has been shown that catalytically inactive deletion
mutants of p300 containing this domain can dominantly inhibit
p53-dependent apoptosis and G1 arrest (Avantaggiati et al.,
1997; Scolnick et al., 1997). Thus, the interaction between p53
and p300 is central to the transcriptional activity of p53.
To better understand the molecular determinants of the inter-
action between p53 TAD1 and Taz2, we used nuclear magneticll rights reserved
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p300 Taz2-p53 TAD1 Modulation by Phosphorylationresonance (NMR) spectroscopy to determine the solution struc-
ture of the complex of these two proteins. The structure reveals
the importance of key hydrophobic interactions in stabilizing the
complex; fluorescence anisotropy binding experiments further
demonstrate the requirement for specific residues for binding.
In addition, isothermal titration calorimetry (ITC) and chemical
shift mapping were used to characterize the binding of phos-
phorylated forms of p53 to Taz2. These experiments suggest
the importance of hydrophobic and specific electrostatic inter-
actions in the stabilization of the p300-p53 complex through
phosphorylation of p53.
RESULTS
Structure Determination of the Taz2/p532-39 Complex
Molecular determinants of the interaction of the human p300
Taz2 domain with p53 TAD1 were investigated in 2D 1H-15N
heteronuclear single quantum correlation (HSQC) experiments
in which unlabeled p532–39 was titrated into
15N-labeled Taz2.
Under the same conditions that were used in an earlier study for
the titration of p5314–28 into
15N-labeled CBP Taz2 (De Guzman
et al., 2000), many Taz2 amide peaks disappeared (see Figure S1
available online). A similar loss of amide signals was reported for
the titration of p300 Taz2 into 15N-labeled p531–57 (Teufel et al.,
2007). To search for conditions that could restore the amide reso-
nances, we varied the pH, salt concentration, and temperature of
the samples and monitored the 2D 1H-15N HSQC spectrum of
Taz2. Under the optimized conditions (35C, 50 mM MES [pH
6.3], 200 mM NaCl, 0.1 mM ZnCl, 1 mM DTT), nearly all Taz2
amide cross-peaks were observed (Figure S1).
Under the optimal conditions described above, we determined
the solution structure of the complex by NMR methods using
isotope-labeled Taz2 or p532-39 proteins. The 3D structures of
the complex were calculated with 1732 NOE-derived distance
constraints, 94 hydrogen bonds, 229 dihedral angle restraints,
Figure 1. Structure of the Taz2-p532–39
Complex
(A) Stereo image of the overlay of ten lowest-
energy NMR structures of the complex between
p5315–27 (magenta) and the Taz2 domain of p300
(gray). The structures are superimposed on the
Ca traces.
(B) Plot of backbone amide 15N-{1H} heteronuclear
NOEs of p532–39.
(C) Cylinder model of the average conformation of
the complex. p53 is shown in magenta and the
helices of Taz2 are shown in blue (a1), lilac (a2),
orange (a3), and red (a4). Zinc ions in Taz2,
modeled as green spheres, were added according
to zinc-coordination distances into the known
binding cage.
(D) Secondary chemical shift difference of p532-39
in the complex (measured Ca chemical shift 
random coil value).
and 52 intermolecular NOEs between
Taz2 and p532-39. The structure of Taz2
in the complex is well defined, whereas
only residues 15–27 of p532–39 are well
defined (Figure 1A and Table 1). The root-mean-square deviation
(rmsd) values for the backbone and all heavy atoms in the folded
regions are 0.31 A˚ and 0.56 A˚, respectively. Less defined regions
in p532–39 showed large dynamic motions, as illustrated by the
low values of heteronuclear 15N-{1H} NOEs (Figure 1B), indi-
cating that the less defined structure in these regions is an
intrinsic feature of the complex. The calculated structures were
further verified by examining the effect of mutations and side-
chain modifications of p53 on the amide 1H and 15N chemical
shifts in Taz2, including p539–33(L14A), p539–33(L22A), p539–
33(L26A), p539–33(E28Q), p539–33(N29D), p539–33(N30D), and
p539–33(V31C-MTSSL). These mutations and modifications
have significant effects only on the amide 1H and 15N chemical
shifts or cross-peak intensities of Taz2 residues that are proximal
to the p53 modification sites in the calculated structures.
Overall Structure of the Complex
In the complex, the p300 Taz2 domain forms four core a helices
with three HCCC-type zinc-binding motifs (Figure 1C). In addi-
tion, a very short helix is observed between helices a2 and a3.
The structure of Taz2 in this complex is very similar to the struc-
ture of free CBP Taz2 (De Guzman et al., 2000). The backbone
rmsd between the structure of free CBP Taz2 and the p300
Taz2-p532–39 complex is 2.0 A˚. Alignment of helices 1-3 of
the free CBP Taz2 and p300 Taz2 complex resulted in a back-
bone rmsd of 1.2 A˚. Whereas free p532-39 displays a highly flex-
ible conformation in solution, it forms a short a-helical confor-
mation within residues 15-27 in complex with Taz2. Chemical
shift analysis revealed that the largest changes in bound p53
compared with a random coil (Wishart et al., 1995) were in resi-
dues 17-24 (Figure 1D). The helical region of p53 interacts with
helices a1, a2, and a3 of Taz2 (Figure 1C). This binding site
corresponds to the site identified previously through chemical
shift mapping for p5314–28 binding to CBP Taz2 (De Guzman
et al., 2000). Complex formation results in a 2300 A˚2 reductionStructure 17, 202–210, February 13, 2009 ª2009 Elsevier Ltd All rights reserved 203
Structure
p300 Taz2-p53 TAD1 Modulation by Phosphorylationin the solvent-accessible surface area, with a reduction of
1100 A˚2 of polar surface area and 1200 A˚2 of nonpolar surface
area.
Interactions between Taz2 and p532-39 at the Interface
At the Taz2-p532–39 interface, interactions were observed
primarily between hydrophobic amino acids with some addi-
tional contributions from charged and polar residues. Phe19 of
p53 is nestled between the hydrophobic parts of the side chains
of Arg1737 and Lys1760 in Taz2 (Figure 2A). The position of the side
chain of Arg1737 differs significantly between the free CBP Taz2
and the complex with p532–39. In CBP Taz2, the side chain was
Table 1. Parameters for the NMR Structures
NMR Distance and Dihedral Constraints
Total NOE 1732
Intraresidues NOE 521
Sequential NOE (ji-jj = 1) 499
Short-range NOE (ji-jj% 4) 473
Long-range NOE (ji-jjR 5) 253
Interprotein NOE 52
H-bonds 94
Dihedral angles 229
Structure Statistics
Violations (mean ± SD)
NOE (all) (A˚) 0.050 ± 0.003
Dihedral () 0.506 ± 0.025
Maximum dihedral angle violation () 3.58
Maximum distance constraint
Violation (A˚) 0.33
Deviations from idealized geometry
Bonds (A˚) 0.0052 ± 0.0005
Angles () 0.724 ± 0.036
Impropers () 0.577 ± 0.026
Average pairwise rmsd (A˚)
All heavy atoms (A˚) 0.56
Backbone atoms (A˚) 0.31
Ramachandran Plots
Most favored regions 88.9% ± 1.0
Allowed regions 8.7% ± 1.1
Generously allowed regions 0.0 ± 0.0
Disallowed regions 2.4% ± 0.2
MolProbity Results
Clashscore, all atom 27.91
Rotamer outliers 5.06%
Ramachandran outliers 8.35%
Ramachandran favored 84.0%
MolProbity score 3.13
Residues with bad bonds 0.0%
Residues with bad angles 0.0%
Residues 1727–1810 in Taz2 and 15–27 in TAD1 were used to calculate
the structural statistics. The 20 lowest-energy structures were used in
the calculation.204 Structure 17, 202–210, February 13, 2009 ª2009 Elsevier Ltd Afound to be flexible among the ensemble of structures, whereas
in the complex, it is less flexible and its orientation along the p53
helix is maintained by interaction with the aromatic ring of Phe19.
In addition, we observed that the amide 1H and 15N resonances
of this residue were highly shifted upon titration of p532–39 (data
not shown). The positively charged amine group on the side
chain of Lys1760 might be stabilized by the p electrons of the
aromatic ring of Phe19. The Ca and Cb of Leu22 form nonpolar
interactions with the side chain of Val1764 and Sd of Met1761.
Additionally, the Leu22 side chain forms contacts with C3 of
Lys1760. The Ca of Leu25 contacts Cg1 and Cd of Ile1781, whereas
the Cd1 and Cd2 of Leu25 contact the side chain of Pro1780
(Figure 2A). Themethyl group of Thr18 of p53 is located in a hydro-
phobic environment made up of the aliphatic portion of Taz2
Gln1784 and Ala1738, Leu1785, and Leu1788.
The importance of the hydrophobic interactions for the
p532-39-Taz2 complex was further demonstrated by analysis
of Taz2 binding to a series of p53 peptides in which a selected
hydrophobic amino acid was replaced by alanine. Fluorescence
anisotropy assays were used to determine the dissociation
constants for the binding of p53 peptides to Taz2 by competition
with fluorescein-labeled p5314–28. No measurable Taz2 binding
was observed for alaninemutants of Phe19, Leu22, or Leu25, three
hydrophobic p53 residues that directly contact Taz2. In contrast,
when Leu26, whose side chain projects away from Taz2 in the
complex, was mutated to alanine, the observed dissociation
constant (Kd = 13.6 ± 4.0 mM) was similar to that of the wild-
type sequence (Kd = 17.6 ± 4.4 mM). The observed binding affin-
ities confirm the importance of specific hydrophobic residues in
Taz2-p532–39 complex formation.
Electrostatic interactions were also apparent at the Taz2-
p532–39 interface. The p53 binding site of Taz2 has areas of posi-
tive charge along the flexible residues N-terminal and C-terminal
to the helix (Figure 2B). In most of the calculated structures, the
carboxylate side chain of p53 Glu11 contacted the guanidinium
group of Taz2 Arg1731 (2.5–4.8 A˚ apart among the ten lowest-
energy structures) (Figure 2C). Because this residue of p53 is
flexible, this interaction might be transient. However, the obser-
vation of intermolecular NOEs between Taz2 and p53 residues in
the flexible regions from 9–14 and 28–31 suggests that these
interactions do take place. Furthermore, large changes in Ca
chemical shifts were also observed for residues 10, 11, 14, and
15 of p53 upon complex formation. A salt bridge was observed
between Taz2 Arg1731 and p53 Glu17 (3.2–4.2 A˚). Specific polar
interactions were seen between the side chains of p53 Asp21
and Taz2 Gln1784 (3.1–5.0 A˚), the hydroxyl group on the side
chain of p53 Thr18 and side chain hydroxyl of Taz2 Ser1734
(2.4–2.5 A˚), the hydroxyl group of p53 Ser15 and the side chain
of Arg1737 (3.4–7.8 A˚), and the side chain of p53 Glu17 and the
hydroxyl of Taz2 Ser1734 (3.5–4.1 A˚).
Because we found that p53 TAD1 and TAD2 bind to Taz2 with
similar affinities (Jenkins et al., 2009), we next used 2D 1H-15N
HSQC experiments to explore the binding site of p53 TAD2 on
Taz2. Titration of p5335–59 into
15N-labeled Taz2 revealed signif-
icant chemical shift changes for multiple amide resonances of
Taz2 (Figure S2A). Some of the affected residues were similarly
shifted upon titration of p532–39 into
15N-labeled Taz2
(Figure S2B), suggesting that TAD1 and TAD2 have overlapping
binding sites on Taz2.ll rights reserved
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p300 Taz2-p53 TAD1 Modulation by PhosphorylationFigure 2. Stabilizing Interactions between p532–39 and Taz2
(A) Model of the Taz2-p532–39 complex, showing residues that make hydro-
phobic contacts. Contacting residues are labeled in white for Taz2 (gray
surface representation) and red for p532–39 (blue ribbon).
(B) Model of the Taz2-p532–39 complex, colored by electrostatic potential (red
represents negative, blue indicates positive). Taz2 is shown in a solid repre-
sentation, and p532–39 as a mesh.Structure 17, 202Modulation of the Interactions between Taz2 and p53
TAD1 by Phosphorylation
An important aspect of the interaction between Taz2 and p53
TAD1 is themodulation of the binding affinity by phosphorylation.
Among the residuesof p53at the interface are two important sites
of phosphorylation, Ser15 and Thr18. In the complex, themethyl of
the Thr18 side chain is in a local hydrophobic environment
whereas the targeted hydroxyl forms a hydrogen bond with
Ser1734 (Figure 2C). Likewise, the targeted hydroxyl of Ser15 is
proximal to the side chain of Arg1737. The local environments of
Ser15 and Thr18 suggest that phosphorylation of these residues
alters the balance of hydrophobic and electrostatic interactions
in the complex. To investigate these effects in detail, ITC experi-
ments were performed in which p53 phosphorylated at Ser15,
Thr18 or both sites was titrated into Taz2 at 15, 25, and 35
C.
Titration of p531–39Ser15p into Taz2 at 35
C was fit by a 1:1
binding model (Figure S3). The binding was exothermic and
was characterized by the dissociation constant Kd = 0.96 mM
(Table 2). This affinity is approximately three times tighter than
that observed for p531-39 (Kd = 2.7 mM), and the change in
enthalpy is 1.2 kcal/mol greater for the phosphorylated form
than the nonphosphorylated form (Jenkins et al., 2009). Similarly,
p531–39Thr18p was titrated into Taz2 at 35
C (Figure S3). The
binding of p531–39Thr18p was exothermic, similar to that of
p531–39Ser15p (Table 2). The affinity of Taz2 for p531–39Thr18p
was 11 times greater than that of p531–39 and 4 times greater
than that of p531–39Ser15p (Table 2). Finally, the diphosphory-
lated peptide, p531–39Ser15p,Thr18p was titrated into Taz2 at
35C (Figure S3). The binding of p531–39Ser15p,Thr18p to Taz2
was also exothermic, although the magnitude was smaller than
that observed for any other form of p531–39. The affinity was
intermediate to that of the two monophosphorylated forms and
approximately seven times larger than nonphosphorylated
p531–39 (Table 2). This result suggests that the stabilization
produced by diphosphorylation at Ser15 and Thr18 is less than
the additive effects of the individual phosphorylations.
At 15C, complex formation by each of the three phosphory-
lated forms is endothermic, whereas at 25C all are close to
zero (Table 2). The magnitude of DH at 15C is greatest for
p531–39Ser15p and p531–39Thr18p, followed by the nonphos-
phorylated form, and is the smallest for p531–39Ser15p,Thr18p.
The value of the heat capacity at constant pressure, DCp, is
similar for the interactions between Taz2 and p531–39Ser15p
and p531–39Thr18p (Table 2); these values are 25%–30% more
negative than the DCp for the interaction of Taz2 with p531–39
observed previously (Jenkins et al., 2009). Hydrophobic and
polar interactions are thought to contribute to the DCp with
opposing signs; thus, a negative DCp suggests that the binding
is dominated by hydrophobic interactions (Baldwin, 1986;
Livingstone et al., 1991; Prabhu and Sharp, 2005). The more
negative value of DCp for the binding of p531–39Ser15p and
p531–39Thr18p to Taz2 suggests that the extent of hydrophobic
interactions is increased in these complexes compared with
the complex with the nonphosphorylated peptide. Interestingly,
although DCp for the interaction between Taz2 and p531–39
(C) Model of the Taz2-p532–39 complex, showing residues that make electro-
static contacts. Contacting residues are labeled in white for Taz2 (gray surface
representation) and red for p532–39 (blue ribbon).–210, February 13, 2009 ª2009 Elsevier Ltd All rights reserved 205
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p300 Taz2-p53 TAD1 Modulation by PhosphorylationSer15p,Thr18p is still negative, the magnitude is only about 45%
that for the formation of the complex with either monophos-
phorylated peptide (Table 2). This value suggests a different
composition of hydrophobic and electrostatic interactions in
the complex of Taz2 with diphosphorylated p53 TAD1.
ITC experiments were performed at lower and higher salt
concentrations to examine ionic contributions to the binding of
p531–39 and phosphorylated forms for Taz2. Compared with
the affinities observed at 100 mM NaCl, the binding of p531–39
and phosphorylated forms were 5 to 10 times tighter at 50 mM
NaCl and correspondingly weaker at 200 mM NaCl (Table 3).
The dependence of the binding affinity on salt concentration
provides information about the net difference in the number of
thermodynamically involved ions upon complex formation. This
analysis suggests that complex formation between p531–39
and Taz2 releases approximately 2 thermodynamically involved
ions, whereas complex formation between Taz2 and p531–39
Ser15p or p531–39Ser15p,Thr18p results in the release of
approximately 3 thermodynamically bound ions. Interestingly,
only approximately 2 thermodynamically involved ions are
released upon binding of p531–39Thr18p, which is similar to the
value for binding the nonphosphorylated peptide. Extrapolation
of the binding constants to 1 M NaCl allows an estimate of the
affinity without the contribution from the release of thermody-
namically involved ions. The extrapolated association constants
for complex formation with p531–39, p531–39Ser15p and p531–39
Ser15p,Thr18p are similar, with the value for p531–39Ser15p
Table 2. Thermodynamic Constants for the Binding of Taz2
to Phosphorylated Forms of p531–39
p531–39
Ser15p
p531–39
Thr18p
p531–39
Ser15p,Thr18p
Kd (mM) 15
C 0.49 ± 0.17 0.40 ± 0.15 0.20 ± 0.07
35C 0.96 ± 0.26 0.23 ± 0.03 0.41 ± 0.09
DH (kcal/mol) 15C 3.91 ± 0.24 4.01 ± 0.22 1.55 ± 0.06
35C 4.68 ± 0.45 4.14 ± 0.36 2.28 ± 0.44
DS (EU)a 15C 42.5 ± 0.1 43.3 ± 0.1 36.2 ± 0.9
35C 12.4 ± 0.9 16.9 ± 1.4 21.9 ± 0.4
DG (kcal/mol) 15C 8.34 ± 0.20 8.44 ± 0.20 8.86 ± 0.21
35C 8.48 ± 0.17 9.35 ± 0.07 9.03 ± 0.31
DCp (cal/mol,K) 429 408 192
Thermodynamic constants were determined by ITC.
a Entropy units.206 Structure 17, 202–210, February 13, 2009 ª2009 Elsevier Ltd Albeing 1.4-fold larger. In contrast, the extrapolated association
constant for p531–39Thr18p is approximately five times larger
than for the unmodified form, suggesting greater differences in
the binding of this phosphorylated form. Thus, although at
moderate salt concentrations, the stabilization resulting from
the release of thermodynamically involved ions is similar for the
Taz2-p531–39Ser15p and Taz2-p531–39Thr18p complexes, the
increased affinity of p531-39Thr18p for Taz2 observed at 0.1 M
NaCl reflects a larger contribution from additional stabilizing
interactions.
Two-dimensional 1H-15N HSQC spectra were collected to
further characterize the effects of Thr18 phosphorylation in
the Taz2-p532–39 complex. Titration of p531–39Thr18p into
15N-labeled Taz2 produced extensive changes in chemical
shifts. Chemical shift mapping demonstrated significant
changes in the amide resonances of Leu1733, Ile1735, Ala1738,
Gln1740, Ser1741, Leu1742, and Gln1784 of Taz2, with smaller
changes observed for Ile1739, Lys1760, and Leu1785 (Figures 3
and S4). Because of the overlap in the 1H-15N HSQC spectra,
we were unable to determine whether the amide chemical shift
of Arg1731 or Arg1732 of Taz2, two basic residues proximal to
the modification site, changed upon addition of the phosphor-
ylated peptide. The results of the chemical shift mapping thus
suggest a rearrangement of residues at the hydrophobic inter-
face, consistent with the thermodynamic results for binding of
Taz2 to p531–39Thr18p.
In the Taz2-p532–39 complex, Ser15 of p53 is proximal to
Arg1737 of Taz2 and, as stated above, Thr18 of p53 is proximal
to Arg1731 and Arg1732 of Taz2 (Figure 2C). To explore the
possible role of these arginine residues in stabilization of the
phosphorylated forms of p53, we separately mutated to alanine
each of these three residues of Taz2 (Arg1731, Arg1732, and
Arg1737) that are closest to p53 Ser15 and Thr18 in the complex.
The CD spectra of all three mutant Taz2 proteins were similar
Table 3. DissociationConstants (mM) forBindingofTaz2top531–39
or Its Phosphorylated Forms at Two Salt Concentrations
50 mM 200 mM
p531–39 0.43 ± 0.30 7.15 ± 3.62
p531–39Ser15p 0.04 ± 0.01 1.83 ± 0.23
p531–39Thr18p 0.05 ± 0.01 1.05 ± 0.16
p531–39Ser15p,Thr18p 0.05 ± 0.00 1.74 ± 0.81
Dissociation constants were determined by ITC at 35C.Figure 3. Effect of p53 Phosphorylation
on Taz2 Conformation
(A) Overlay of a selected region of 2D 1H-15N
HSQC spectra of 15N-labeled Taz2 complexed
with p532–39 (black) and in complex with p531–39
Thr18p (red).
(B) Model of Taz2-p532–39 complex showing resi-
dueswith significant changes in their amide chem-
ical shifts upon addition of p531–39Thr18p. Resi-
dues of Taz2 (space-fill) with chemical shift
changes shown in magenta; the two nearby argi-
nine residues of Taz2 are shown in purple. The
side chain of Thr18 of p53 (blue ribbon) is shown
as sticks.l rights reserved
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similarly (Figure S5). The binding of the mutant peptides were
then examined by ITC at 35C. All three mutant Taz2 proteins
bound nonphosphorylated p531–39 with affinities similar to
Taz2 (Table 4). Surprisingly, the binding affinity of Taz2(R1737A)
to p531–39Ser15p was approximately 4-fold greater than to the
nonphosphorylated form (Table 4), similar to the binding of this
peptide to Taz2. Although p53 Ser15 and Taz2 Arg1737 are close
to one another in the structure, Ser15 is located in a flexible region
of p53, so this residuemight be able to be stabilized by a different
residue in the Taz2(R1737A) mutant or the phosphorylated
protein may bind in a different manner than does the
nonphosphorylated peptide. In contrast, Taz2(R1731A) and
Taz2(R1732A) bound p531–39Thr18p 5.5 times more tightly
than the nonphosphorylated form (Table 4). This binding is two
times weaker than observed for the binding of Taz2 to p532-39
Thr18p, suggesting that both Arg1731 and Arg1732 play a role in
stabilization of p531–39Thr18p, consistent with their proximity
to Thr18 in the complex. The lack of a larger difference in binding
by the twomutantsmight be due to stabilization of the phosphor-
ylation by the alternate arginine residue or a difference in binding
of the nonphosphorylated and phosphorylated peptides.
DISCUSSION
The p53 TAD has been described as intrinsically disordered
(Dunker et al., 2005). Frequently, intrinsically disordered protein
domains are able to take on a number of conformations, partic-
ularly in complex with other proteins, to effect different biological
outcomes (Vise et al., 2007). In the free form, the TAD of p53 is
flexible and unstructured. Recently, it has been demonstrated
that TAD1 forms a dynamic a helix, whereas two turns can be
observed within TAD2 (Lee et al., 2000; Vise et al., 2005). This
dynamic structure allows p53 to be involved in a variety of
cellular responses by conforming to the proteins with which it
interacts. In four previously determined structures of p53 TAD
peptides in complex with proteins, both TAD1 and TAD2 formed
short a helices and the binding was mediated by hydrophobic
interactions (Bochkareva et al., 2005; Di Lello et al., 2006; Kussie
et al., 1996; Popowicz et al., 2008).
The complex of p53 TAD1 with Taz2 is similar to the
complexes formed with MDM2 and MDMX, in which p5318–26
forms an amphipathic helix. Although hydrophobic interactions
are important in all three interfaces, the specific residues
involved in the interactions differ. In the MDM2 and MDMX
complexes, Phe19, Trp23, and Leu26 form the primary hydro-
phobic interactions, whereas in the Taz2 complex we find that
Phe19, Leu22, and Leu25 are the most critical. Indeed, Trp23 and
Table 4. Dissociation Constants for Binding of Taz2 Mutants
to p531–39 or its Phosphorylated Forms (mM)
Taz2
Taz2
R1731A
Taz2
R1732A
Taz2
R1737A
p531–39 2.7 ± 0.5 3.5 ± 1.1 3.7 ± 1.0 3.6 ± 1.1
p531–39 Ser15p 0.96 ± 0.26 ND
a ND 0.91 ± 0. 12
p531–39 Thr18p 0.23 ± 0.03 0.72 ± 0.16 0.68 ± 0.01 ND
Dissociation constants were determined by ITC at 35C.
aNot determined.Structure 17, 202Leu26 project away from Taz2, whereas Leu25 projects away
from MDM2 (Figure S6). We further observed that mutation of
Leu26, important for MDM2 binding, did not affect binding of
p53 to Taz2. In addition, although it is not buried in the
hydrophobic pocket on MDM2 (Figure S6B), p53 Leu22 makes
hydrophobic interactions that stabilize the complex (Kussie
et al., 1996). As observed for p53 binding to Taz2, mutation of
Leu22 to alanine also disrupts binding of p53 to MDM2 (Picksley
et al., 1994). Although both complexes involve binding to a-
helical regions of p53, the binding of p53 to MDM2 requires
a shorter segment of p53 and has a higher affinity. In contrast,
we found that the binding of p53 to Taz2 is approximately an
order of magnitude weaker (Kd = 0.4 mM for binding to MDM2
and 3 mM for binding to Taz2) and involves a longer region of
p53. The structure of the p53/MDM2 complex shows that p53
fits into a deep hydrophobic cleft on MDM2, with key hydro-
phobic residues buried in the interface. Although the interaction
with Taz2 also involves hydrophobic interactions, p53 lies across
the surface of Taz2 formed by helices a1, a2, and a3. The
extended interaction site of p53 TAD1 on Taz2 is reflected in
the greater loss of solvent-accessible surface area for this
complex than that calculated for the MDM2-p5315–29 complex
(Kussie et al., 1996). The Taz2-p532–39 complex shares common
features with other complexes of intrinsically disordered
domains, including large interaction area, large exposed surface
area per residue, and binding through a single continuous
segment of the protein (Meszaros et al., 2007). Based upon the
observed changes in polar and nonpolar solvent accessible
surface area upon Taz2-p532–39 complexation, we estimated
DCp for complex formation to be 244 cal/mol,K (Loladze
et al., 2001). This value is very similar to value ofDCp determined
from thermodynamic measurements (Jenkins et al., 2009).
Our structural and binding studies allow better understanding
of the molecular basis for the increased binding affinity between
Taz2 and p531–39 upon phosphorylation at Ser15 and Thr18. In the
Taz2-p532–39 complex, p53 Ser15 and Thr18 are located in a basic
environment on Taz2 (Figure 2); thus, phosphorylation at these
sites contributes to increased affinity through stabilizing interac-
tions. Similarly, it has been suggested that the decreased affinity
of phosphorylated p53 for MDM2 is due to a local acidic environ-
ment near Thr18 and Ser20 on MDM2 that repels these residues
when phosphorylated (Lee et al., 2007). Because phosphoryla-
tion has been suggested to stabilize helical conformation when
it occurs at the N terminus (Smart andMcCammon, 1999), modi-
fication of Ser15 might also stabilize the p53 helix, thereby
increasing the affinity for Taz2. Although Arg1731 and Arg1732
play a role in stabilization of phosphorylation at Thr18 (Table 4),
the more negative DCp for the modified form compared to the
nonphosphorylated form (Table 2) suggests that, consistent
with changes observed in the chemical shift mapping experi-
ments, the extent of hydrophobic interactions increased for
p531–39Thr18p. The less negative DCp observed for binding of
p532–39Ser15p,Thr18p to Taz2 (Table 2) suggests an increase
in electrostatic interactions in this complex and/or a decrease
in the extent of hydrophobic interactions, possibly due to confor-
mational restriction imposed by the two modifications. Thus, the
structural and thermodynamic data suggest a means for modu-
lation of the interaction of Taz2 and p53 TAD1 upon p53 phos-
phorylation.–210, February 13, 2009 ª2009 Elsevier Ltd All rights reserved 207
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p300 Taz2-p53 TAD1 Modulation by PhosphorylationThe interaction between p53 and the Taz2 domain of p300 is
crucial for p53 activity, and biological experiments have shown
that phosphorylation modulates this interaction (Avantaggiati
et al., 1997). The increased affinity for Taz2 upon p53 phosphor-
ylation might amplify the p53 response through repression of
alternate signaling pathways. Following DNA damage-induced
p53 phosphorylation, the increased affinity of p53 for p300might
reduce the interaction of p300 with other transcription factors
through competition, thereby decreasing their activity while
increasing that of p53. Acetylation of p53 by p300 might further
enhance this effect by promoting coactivator recruitment by
p53 and subsequent histone acetylation (Barlev et al., 2001).
This mechanism of repression by p53 would allow for amplifica-
tion of the p53 response to DNA damage, an effect necessary to
elicit cell cycle arrest or apoptosis. Additionally, phosphorylation
of p53 on Thr18 results in weaker binding to MDM2, disrupting
the MDM2/p53 complex and allowing p53 to recruit p300.
The structural studies presented here describe the molecular
determinants of the binding of p53 TAD1 to the Taz2 domain of
p300, a crucial interaction for p53-mediated transcriptional
activation. The interaction is stabilized in part by hydrophobic
interactions, mediated by Phe19, Leu22, and Leu25. In addition,
the extent of hydrophobic interaction is also increased upon
p53 phosphorylation at either Ser15 or Thr18, suggesting
a possible rearrangement of the interaction with the phosphory-
lated protein as compared with the unmodified form. These vital
modifications control the response of p53 following DNA
damage by modulating its affinity for other proteins and thereby
controlling whether it is degraded or stabilized and activated.
Thus, details of how posttranslational modifications regulate
the protein-protein interactions of p53 at the molecular level
are required to fully understand its functions.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant Proteins
The cloning, expression, and purification of Taz2 (A1723-K1812/C1738A,
C1746A, C1789A, C1790A) has been previously described (Jenkins et al.,
2009); this protein contains alanine mutations of four cysteine residues not
involved in zinc coordination and maintains similar secondary structure and
p53-binding characteristics as the wild-type protein, as expected from the
characteristics of the similarly mutated Taz2 domain of CBP (De Guzman
et al., 2000). Site-directed mutagenesis of Taz2 was performed using the
QuikChange Mutagenesis Kit (Stratagene). Uniformly (>98%) 15N-labeled or
15N/13C-labeled Taz2wasprepared inCeltonemedia (SpectraStable Isotopes)
supplemented with 15N ammonium chloride and 13C6-D-glucose as the sole
nitrogen and carbon source, respectively. The coding sequence for p532–39
was polymerase chain reaction amplified from amammalian vector containing
p53 cDNA using the following primers: 50-TGGATCCGAGGAGCCGCAGTC
AGAT-30 and 50-GGAATTCTCATGCTTGGGACGGCAAG-30. The amplified
coding sequence was subcloned into pGEX4T-1 (GE Healthcare) using the
BamHI and EcoRI restriction sites. GST-p532–39 was grown in E. coli in LB or
minimal media containing 15N-ammonium chloride and 13C-glucose as the
sole nitrogen and carbon sources, respectively. The cultures were grown at
37C to OD600 0.6 and induced with 0.5 mM IPTG for 3 hr. The cells were
spun down and resuspended in 50 mM Tris-HCl (pH 8), 120 mM NaCl, 0.5%
NP-40, and 2 mM DTT (EBC buffer) and protease inhibitors (Roche Applied
Science). The resuspended cells were lysed by French pressure cell and
spun at 13,000 3 g for 1 hr. The supernatant was incubated 16 hr at 4C with
glutathione sepharose (GE Healthcare) equilibrated with EBC buffer, and the
bound fusion protein washed with EBC, re-equilibrated in phosphate-buffered
saline, and digested with 100 U thrombin (EMD Biosciences) for 4 hr at 25C.
The cleaved protein was further purified to > 95% purity using reversed-phase208 Structure 17, 202–210, February 13, 2009 ª2009 Elsevier Ltd Ahigh-performance liquid chromatography (RP-HPLC) on a C-18 column with
0.05% TFA/water/acetonitrile. The mass of the protein was confirmed by
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass
spectrometry (Waters).
Peptide Synthesis
Peptides were synthesized by the solid phase method with 9-fluorenylme-
thoxycarbonyl (Fmoc) chemistry. Phospho-amino acids were coupled as
Fmoc-Thr[PO(OBzl)OH]-OH and Fmoc-Ser[PO(OBzl)OH]-OH (Novabiochem).
Fluorescence labeling of the peptide was achieved with 3 equivalents of
5-(6)-carboxyfluorescein succiniimidyl ester (Molecular Probes) in dimethyl-
sulfoxide stirred overnight at 25C in the dark. The peptides were cleaved
with a solution of 82.5% trifluoroacetic acid (TFA), 5% phenol, 5% thioani-
sole, 5% water, and 2.5% ethandithiol, and then purified to >95% purity
by RP-HPLC on a C-4 column with 0.05% TFA/water/acetonitrile and
masses confirmed by MALDI-TOF mass spectrometry (Waters).
NMR Spectroscopy
All NMR experiments were done at 35C and pH 6.3 (50 mM MES, 200 mM
NaCl, 0.1 mM ZnCl, 1 mM DTT) on a Bruker 500 MHz spectrometer equipped
with pulsed-field gradient units and triple resonance probes. Chemical shifts
(1H, 15N, and 13C) and NOEs of Taz2 and p532–39 were determined by per-
forming standard triple-resonance experiments (Bax and Grzesiek, 1993).
Intermolecular NOEs were obtained from 15N-edited nuclear Overhauser
enhancement spectroscopy experiments on 15N, 2H/1H-labeled p532–39
complexed with Taz2. NMR data were processed with NMRPipe/NMRDraw
(Delaglio et al., 1995), and analyzed with NMRView (Johnson and Blevins,
1994). To confirm the NOEs, mutations and site-directed paramagnetic
spin-labeling in p532–39 were used to identify the neighboring residues of
the mutation site. Heteronuclear 15N-{1H} NOE experiments and analysis of
the results were performed as described previously (Feng et al., 2005).
Structure Calculations
The NOE-derived restraints were subdivided into four classes as strong (1.8–
2.7 A˚), medium (1.8–3.3 A˚), weak (1.8–5.0 A˚), and very weak (1.8–6.0 A˚), by
comparison with NOEs of protons separated by known distances. An addi-
tional 0.5 A˚ was added to the upper distance limit for methyl protons and
0.2 A˚ was added to the upper distance limit for NH protons if the NOEs were
in the strong and medium classes. Backbone dihedral angle restraints (4
and c angles) were obtained from analysis of 1Ha, HN,
13Ca,
13Cb,
13CO, and
15N chemical shifts using the program TALOS (Cornilescu et al., 1999). Two
constraints per hydrogen bond (dNH-O% 2.2 A˚ and dN-O% 3.2 A˚) were added
in the final structure calculation after initial NOE-derived structures were
obtained. Structures were calculated using conjoined rigid body/torsion angle
simulated annealing with the program Xplor-NIH (Cornilescu et al., 2002;
Schwieters and Clore, 2001; Schwieters et al., 2003). Zn2+ ions were not
included in the structure calculation. The quality of the 20 lowest-energy struc-
tures was analyzed by using the programs PROCHECK_NMR and MolProbity
(Davis et al., 2007; Laskowski et al., 1996). Calculation of the buried surface
areawas performed using Surface Racer 5.0 (Tsodikov et al., 2002); the acces-
sible surface area for helical residues of p53 were replaced with the reported
median accessibilities for random coil conformations (Lins et al., 2003). Molec-
ular graphics images were produced using the UCSF Chimera package (Pet-
tersen et al., 2004) and DSViewer 2.0 (Accelrys).
Fluorescence Polarization Binding Assay
Taz2 (0.001–100 mM) was incubated with 10 nM fluorescein-labeled p5314–28
in 20 mM acetate buffer (pH 6.0), 200 mM NaCl, 5% glycerol, 3.0 equivalents
ZnCl2, and 0.1 mg/ml bovine serum albumin (BSA) 1 hr at 25
C. Fluores-
cence anisotropy was measured at 25C on a Beacon 2000 (PanVera). The
equilibrium association constant Ks, was estimated by nonlinear curve fitting
of the observed anisotropies using Origin software (MicroCal). Equilibrium
association constants for the binding of nonlabeled p53 peptides to Taz2
were determined by a fluorescence anisotropy competition assay. p53
peptides (0.001–300 mM), 1.0 mM Taz2, and 10 nM fluorescein-labeled
p5314–28 peptide were incubated 1 hr at 25
C in 10 mM acetate buffer
(pH 6.0), 200 mM NaCl, 5% glycerol, 6 mM ZnCl2, and 0.1 mg/ml BSA. Thell rights reserved
Structure
p300 Taz2-p53 TAD1 Modulation by Phosphorylationequilibrium dissociation constants, Kd, were estimated by nonlinear curve
fitting of the observed anisotropies.
Isothermal Titration Calorimetry
ITC measurements were performed using a VP-ITC calorimeter (MicroCal).
Most titrations were performed in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl,
and 2 mM b-mercaptoethanol at 15C, 25C, or 35C as specified. Experi-
ments to determine the effect of salt concentration on binding were performed
at 35C in 20 mM Tris-HCl (pH 7.5), 2 mM b-mercaptoethanol, and 50, 100, or
200 mM NaCl, as specified. The protein and peptide solutions were degassed
before each experiment. Heats of dilution were subtracted from the raw data.
ITC experiments with p531–39 phosphopeptides binding to Taz2 were fit with
a 1:1 binding model using Origin software with the ITC package (Microcal).
All experiments were performed at least two times.
ACCESSION NUMBERS
The final coordinates of the Taz2/p532–39 complex have been deposited with
the Protein Data Bank under the accession code 2K8F.
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